Skip to main content

Published locations for FDA approves ibrutinib with rituximab in Waldenström’s macroglobulinemia

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves ibrutinib with rituximab in Waldenström’s macroglobulinemia

User login

  • Reset your password
  • /content/fda-approves-ibrutinib-rituximab-waldenstroms-macroglobulinemia
  • /hematologynews/article/173491/indolent-lymphoma/fda-approves-ibrutinib-rituximab-waldenstroms
  • /oncologypractice/article/173491/indolent-lymphoma/fda-approves-ibrutinib-rituximab-waldenstroms
  • /hematologynews/nhlhub/article/173491/indolent-lymphoma/fda-approves-ibrutinib-rituximab-waldenstroms
  • /hematology-oncology/article/173491/indolent-lymphoma/fda-approves-ibrutinib-rituximab-waldenstroms